Status:
RECRUITING
The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Inflammatory Bowel Diseases
Neutropenia
Eligibility:
All Genders
1-25 years
Brief Summary
The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, i...
Detailed Description
In inflammatory bowel disease (IBD), thiopurines play an important role in maintenance of steroid-free remission but possess risk of life-threatening neutropenia, which is associated with gene variant...
Eligibility Criteria
Inclusion
- Participants who are diagnosed with inflammatory bowel disease.
Exclusion
- Participants who refused to have blood test for NUDT15 gene evaluation.
Key Trial Info
Start Date :
December 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06913998
Start Date
December 27 2023
End Date
November 1 2026
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100